133 related articles for article (PubMed ID: 4008513)
1. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
[TBL] [Abstract][Full Text] [Related]
2. Misonidazole combined with hyperfractionation in the management of malignant glioma.
Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
[TBL] [Abstract][Full Text] [Related]
3. Misonidazole and radiotherapy to treat malignant glioma: a phase II trial of the radiation therapy oncology group.
Carabell SC; Bruno LA; Weinstein AS; Richter MP; Chang CH; Weiler CB; Goodman RL
Int J Radiat Oncol Biol Phys; 1981 Jan; 7(1):71-7. PubMed ID: 7263341
[No Abstract] [Full Text] [Related]
4. Treatment of autochthonous rat brain tumors with fractionated radiotherapy. The effects of graded radiation doses and of combined therapy with BCNU or steroids.
Steinbok P; Mahaley MS; U R; Varia MA; Lipper S; Mahaley J; Dalzell JG; Bigner DD
J Neurosurg; 1980 Jul; 53(1):68-72. PubMed ID: 7411210
[TBL] [Abstract][Full Text] [Related]
5. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
7. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Bleehen NM
Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
9. [Experimental studies on radiosensitization of hypoxic cancer cells].
Omura M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1972-80. PubMed ID: 6663130
[TBL] [Abstract][Full Text] [Related]
10. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
[TBL] [Abstract][Full Text] [Related]
11. The effect of a hypoxic cell sensitizer on cancer radiotherapy: an analysis by a model.
Okumura Y; Okajima S
Strahlentherapie; 1984 Oct; 160(10):620-3. PubMed ID: 6495356
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
[TBL] [Abstract][Full Text] [Related]
13. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.
Ang KK; van der Schueren E; Notter G; Horiot JC; Chenal C; Fauchon F; Raps J; van Peperzeel H; Goffin JC; Vessière M; van Glabbeke M
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1657-64. PubMed ID: 6818185
[No Abstract] [Full Text] [Related]
14. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
[TBL] [Abstract][Full Text] [Related]
15. [Flow-microfluorometric studies on the effect of misonidazole as a radiosensitizer for human uterine cervical carcinoma transplanted to nude mice].
Kishino Y
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2368-76. PubMed ID: 6663145
[TBL] [Abstract][Full Text] [Related]
16. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Grdina DJ; Sigdestad CP; Jovonovich JA
Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
[TBL] [Abstract][Full Text] [Related]
17. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
[TBL] [Abstract][Full Text] [Related]
18. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
[TBL] [Abstract][Full Text] [Related]
19. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Tamulevicius P; Bamberg M; Scherer E; Streffer C
Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
[TBL] [Abstract][Full Text] [Related]
20. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
Abratt RP
Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
